2011Journal of Guangdong Pharmaceutical UniversityRequires access

Determination of venlafaxine in human plasma and bioequivalence with HPLC-MS/MS

Li Guo

Open publisher page 0 citations

Abstract

Objective To investigate the bioequivalence of venlafaxine hydrochloride capsules in Chinese healthy volunteers.Methods 50 mg test preparation and reference preparation were given to 24 male healthy volunteers in randomized two-way crossover design and blood samples in 36 h were collected.HPLC-MS/MS was used to determine plasma concentrations of venlafaxine.The pharmacokinetics and relative bioavailability were calculated by DAS to evaluate bioequivalence.Results The main pharmacokinetic parameters of the two preparation were as follows: Cmax were(59.32±17.21) and(60.58±17.42) μg·L-1,Tmax were(2.08±0.46) and(2.25±0.55) h,T1/2 were(6.69±1.67) and(6.35±1.69) h,AUC0-36 were(524.65±227.01) and(528.22±226.57) μg·L-1·h,AUC0-∞were(544.81±246.05) and(546.85±244.62) μg·L-1·h,respectively.The mean relative bioavailability of test preparation and reference preparation were(100.37±10.41)%.Conclusion The statistical analysis shows the two preparations are bioequivalent.

About this research paper

What this paper is about

Objective To investigate the bioequivalence of venlafaxine hydrochloride capsules in Chinese healthy volunteers.Methods 50 mg test preparation and reference preparation were given to 24 male healthy volunteers in randomized two-way crossover design and blood samples in 36 h were collected.HPLC-MS/MS was used to determine plasma concentrations of venlafaxine.The pharmacokinetics and relative bioavailability were calculated by DAS to evaluate bioequivalence.Results The main pharmacokinetic parameters of the two preparation were as follows: Cmax were(59.32±17.21) and(60.58±17.42) μg·L-1,Tmax were(2.08±0.46) and(2.25±0.55) h,T1/2 were(6.69±1.67) and(6.35±1.69) h,AUC0-36 were(524.65±227.01) and(528.22±226.57) μg·L-1·h,AUC0-∞were(544.81±246.05) and(546.85±244.62) μg·L-1·h,respectively.The mean relative bioavailability of test preparation and reference preparation were(100.37±10.41)%.Conclusion The statistical analysis shows the two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the bioequivalence of venlafaxine hydrochloride capsules in Chinese healthy volunteers.Methods 50 mg test preparation and reference preparation were given to 24 male healthy volunteers in randomized two-way crossover design and blood samples in 36 h were collected.HPLC-MS/MS was used to determine plasma concentrations of venlafaxine.The pharmacokinetics and relative bioavailability were calculated by DAS to evaluate bioequivalence.Results The main pharmacokinetic parameters of the two preparation were as follows: Cmax were(59.32±17.21) and(60.58±17.42) μg·L-1,Tmax were(2.08±0.46) and(2.25±0.55) h,T1/2 were(6.69±1.67) and(6.35±1.69) h,AUC0-36 were(524.65±227.01) and(528.22±226.57) μg·L-1·h,AUC0-∞were(544.81±246.05) and(546.85±244.62) μg·L-1·h,respectively.The mean relative bioavailability of test preparation and reference preparation were(100.37±10.41)%.Conclusion The statistical analysis shows the two preparations are bioequivalent.

Key concepts: Bioequivalence, Cmax, Bioavailability, Pharmacokinetics, Venlafaxine, Chromatography, Crossover study, Venlafaxine Hydrochloride

Related papers

Back to paper searchBrowse research topicsOriginal source
Determination of venlafaxine in human plasma and bioequivalence with HPLC-MS/MS — Research Paper | ScholarLens